UNITY BIOTECHNOLOGY INC - COM (UBX)

CUSIP: 91381U101

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COM
Total 13F shares
12,614,335
Share change
-1,993,760
Total reported value
$14,118,580
Put/Call ratio
9.7%
Price per share
$1.12
Number of holders
56
Value change
-$2,709,982
Number of buys
23
Number of sells
28

Quarterly Holders Quick Answers

What is CUSIP 91381U101?
CUSIP 91381U101 identifies UBX - UNITY BIOTECHNOLOGY INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of UNITY BIOTECHNOLOGY INC - COM (UBX) as of Q1 2022

As of 31 Mar 2022, UNITY BIOTECHNOLOGY INC - COM (UBX) was held by 56 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,614,335 shares. The largest 10 holders included FMR LLC, PURA VIDA INVESTMENTS, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, GSA CAPITAL PARTNERS LLP, MARSHALL WACE, LLP, BAILLIE GIFFORD & CO, BlackRock Inc., and Founders Fund V Management, LLC. This page lists 56 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.